Physician profile
Donna Kaplan
NPI 1821004003
$446.29
in general payments reported to CMS, 2019-2025
12 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $38.27 · 2023: $24.83 · 2024: $149 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $146.93 | 2023-2025 | |
| Astellas Pharma US INC | $60.06 | 2021 | |
| Urovant Sciences INC | $47.32 | 2021-2022 | |
| Viiv Healthcare Company | $30.23 | 2021 | |
| Dentsply Ih Ab | $24.22 | 2024 | Lofric |
| Abbvie INC. | $24.02 | 2025 | |
| Sumitomo Pharma America, INC. | $23.43 | 2024 | Gemtesa |
| Teleflex LLC | $20.60 | 2025 | Barrigel |
| Ferring Pharmaceuticals INC. | $18.52 | 2024 | Adstiladrin |
| Myovant Sciences INC. | $18.31 | 2021 | |
| Antares Pharma, INC. | $17.66 | 2024 | Xyosted |
| Kowa Pharmaceuticals America, INC. | $14.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.